HRTX Q4 2019 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+21.6% YoY

Gross Profit

$19M54.8% margin

Operating Income

-$59M-169.2% margin

Net Income

-$58M-165.1% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

-17.7%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$31M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$513M

Total Liabilities

$109M

Stockholders' Equity

$404M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$29M	+21.6%
Gross Profit	$19M	$17M	+11.2%
Operating Income	-$59M	-$51M	-15.7%
Net Income	-$58M	-$50M	-16.9%

Revenue Segments

C I N V A N T I

$35M99%

S U S T O L

$500,0001%